INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Lisanti Capital Growth, LLC's Holding History (CIK: 0001424467)

Note: Option positions (PUT/CALL) are excluded.

Q3 2013
Shares 13,225 Value ($000) $913 Avg Close — Range —
Q2 2013
Shares 13,585 Value ($000) $636 Avg Close — Range —